Cargando…
Sources, Production, and Clinical Treatments of Milk Fat Globule Membrane for Infant Nutrition and Well-Being
Research on milk fat globule membrane (MFGM) is gaining traction. The interest is two-fold; on the one hand, it is a unique trilayer structure with specific secretory function. On the other hand, it is the basis for ingredients with the presence of phospho- and sphingolipids and glycoproteins, which...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352329/ https://www.ncbi.nlm.nih.gov/pubmed/32486129 http://dx.doi.org/10.3390/nu12061607 |
_version_ | 1783557612468436992 |
---|---|
author | Fontecha, Javier Brink, Lauren Wu, Steven Pouliot, Yves Visioli, Francesco Jiménez-Flores, Rafael |
author_facet | Fontecha, Javier Brink, Lauren Wu, Steven Pouliot, Yves Visioli, Francesco Jiménez-Flores, Rafael |
author_sort | Fontecha, Javier |
collection | PubMed |
description | Research on milk fat globule membrane (MFGM) is gaining traction. The interest is two-fold; on the one hand, it is a unique trilayer structure with specific secretory function. On the other hand, it is the basis for ingredients with the presence of phospho- and sphingolipids and glycoproteins, which are being used as food ingredients with valuable functionality, in particular, for use as a supplement in infant nutrition. This last application is at the center of this Review, which aims to contribute to understanding MFGM’s function in the proper development of immunity, cognition, and intestinal trophism, in addition to other potential effects such as prevention of diseases including cardiovascular disease, impaired bone turnover and inflammation, skin conditions, and infections as well as age-associated cognitive decline and muscle loss. The phospholipid composition of MFGM from bovine milk is quite like human milk and, although there are some differences due to dairy processing, these do not result in a chemical change. The MFGM ingredients, as used to improve the formulation in different clinical studies, have indeed increased the presence of phospholipids, sphingolipids, glycolipids, and glycoproteins with the resulting benefits of different outcomes (especially immune and cognitive outcomes) with no reported adverse effects. Nevertheless, the precise mechanism(s) of action of MFGM remain to be elucidated and further basic investigation is warranted. |
format | Online Article Text |
id | pubmed-7352329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73523292020-07-21 Sources, Production, and Clinical Treatments of Milk Fat Globule Membrane for Infant Nutrition and Well-Being Fontecha, Javier Brink, Lauren Wu, Steven Pouliot, Yves Visioli, Francesco Jiménez-Flores, Rafael Nutrients Review Research on milk fat globule membrane (MFGM) is gaining traction. The interest is two-fold; on the one hand, it is a unique trilayer structure with specific secretory function. On the other hand, it is the basis for ingredients with the presence of phospho- and sphingolipids and glycoproteins, which are being used as food ingredients with valuable functionality, in particular, for use as a supplement in infant nutrition. This last application is at the center of this Review, which aims to contribute to understanding MFGM’s function in the proper development of immunity, cognition, and intestinal trophism, in addition to other potential effects such as prevention of diseases including cardiovascular disease, impaired bone turnover and inflammation, skin conditions, and infections as well as age-associated cognitive decline and muscle loss. The phospholipid composition of MFGM from bovine milk is quite like human milk and, although there are some differences due to dairy processing, these do not result in a chemical change. The MFGM ingredients, as used to improve the formulation in different clinical studies, have indeed increased the presence of phospholipids, sphingolipids, glycolipids, and glycoproteins with the resulting benefits of different outcomes (especially immune and cognitive outcomes) with no reported adverse effects. Nevertheless, the precise mechanism(s) of action of MFGM remain to be elucidated and further basic investigation is warranted. MDPI 2020-05-30 /pmc/articles/PMC7352329/ /pubmed/32486129 http://dx.doi.org/10.3390/nu12061607 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Fontecha, Javier Brink, Lauren Wu, Steven Pouliot, Yves Visioli, Francesco Jiménez-Flores, Rafael Sources, Production, and Clinical Treatments of Milk Fat Globule Membrane for Infant Nutrition and Well-Being |
title | Sources, Production, and Clinical Treatments of Milk Fat Globule Membrane for Infant Nutrition and Well-Being |
title_full | Sources, Production, and Clinical Treatments of Milk Fat Globule Membrane for Infant Nutrition and Well-Being |
title_fullStr | Sources, Production, and Clinical Treatments of Milk Fat Globule Membrane for Infant Nutrition and Well-Being |
title_full_unstemmed | Sources, Production, and Clinical Treatments of Milk Fat Globule Membrane for Infant Nutrition and Well-Being |
title_short | Sources, Production, and Clinical Treatments of Milk Fat Globule Membrane for Infant Nutrition and Well-Being |
title_sort | sources, production, and clinical treatments of milk fat globule membrane for infant nutrition and well-being |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352329/ https://www.ncbi.nlm.nih.gov/pubmed/32486129 http://dx.doi.org/10.3390/nu12061607 |
work_keys_str_mv | AT fontechajavier sourcesproductionandclinicaltreatmentsofmilkfatglobulemembraneforinfantnutritionandwellbeing AT brinklauren sourcesproductionandclinicaltreatmentsofmilkfatglobulemembraneforinfantnutritionandwellbeing AT wusteven sourcesproductionandclinicaltreatmentsofmilkfatglobulemembraneforinfantnutritionandwellbeing AT pouliotyves sourcesproductionandclinicaltreatmentsofmilkfatglobulemembraneforinfantnutritionandwellbeing AT visiolifrancesco sourcesproductionandclinicaltreatmentsofmilkfatglobulemembraneforinfantnutritionandwellbeing AT jimenezfloresrafael sourcesproductionandclinicaltreatmentsofmilkfatglobulemembraneforinfantnutritionandwellbeing |